Social Starts

Social Starts is a venture capital firm that focuses on early-stage investments in the technology, health tech, internet, and mobile tech sectors. Established as the first venture capital partnership dedicated to the emerging science of individual health, the firm aims to enhance well-being and happiness through its investments. It operates several funds, including Social Starts A, Social Starts 1 through 3, and Joyance Partners in the US and Europe. The firm seeks to identify and support top technologists and scientists globally, helping them advance innovations in health, biotechnology, and therapeutics. By leveraging advancements in medical care, prevention, personalization, and artificial intelligence, Social Starts believes it can capitalize on significant investment opportunities that promote health and happiness.

Kevin Dasch

COO

Toshi Eguchi

Partner

Julien Tizot

Venture Partner

Maria Zhang

Venture Partner

Chris Kurdziel

Venture Partner

Past deals in Wearables

Epicore Biosystems

Series A in 2022
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company founded in 2017 that specializes in developing and commercializing a wearable microfluidic sensing platform. This innovative technology analyzes small droplets of sweat directly from the skin to provide insights into health, hydration, and athletic performance. The platform is designed to measure various biomarkers, including proteomics and inflammatory markers, allowing for personalized management of health and nutrition. Epicore's approach leverages over two decades of research in microfluidics and soft materials conducted by leading experts at Northwestern University. By offering a non-invasive and cost-effective solution, Epicore aims to enhance athletic performance and improve overall health monitoring for users.

Sharper Sense

Seed Round in 2021
Sharper Sense is a company focused on wearable neurotechnology designed to enhance sensory acuity, including vision, hearing, and touch. The firm has developed a neuromodulation patch that employs comfortable, noninvasive electrical stimulation to improve sensory processing. This technology has both clinical and commercial applications, particularly in treating sensory processing disorders and sensory loss. By enhancing performance and safety, Sharper Sense aims to provide users with a clearer and more accurate perception of their surroundings.

Zone7

Venture Round in 2020
Zone7 is a technology company founded in 2017 and based in Palo Alto, California, specializing in artificial intelligence-driven sports injury prediction software. The platform leverages data from wearable devices, medical records, and fitness profiles to forecast potential injuries, allowing for proactive measures to enhance athlete safety and performance. Zone7 serves over 30 professional sports franchises, offering insights that enable coaching staff to monitor athlete performance and injury risk effectively. Additionally, the technology is utilized in hospitals to ensure the well-being of medical staff by providing actionable recommendations for optimizing workload and recovery. By analyzing various data sources, Zone7 aims to protect and enhance the health and performance of both athletes and the elite workforce.

Noctrix Health

Funding Round in 2020
Noctrix Health, Inc. is an early-stage medical device company based in Menlo Park, California, founded in 2018. The company specializes in developing therapeutic wearable devices aimed at treating chronic neurological and sleep disorders, particularly focusing on restless leg syndrome. Its innovative device utilizes neural circuitry to alleviate symptoms and promote undisturbed sleep, empowering patients to better manage their chronic medical conditions.

H2L

Venture Round in 2019
H2L Inc. is a Tokyo-based company that focuses on researching and developing electric stimulation devices to enhance human interaction with virtual environments. Founded in 2012, H2L offers innovative products such as UnlimitedHand, a virtual reality gaming controller that utilizes electronic muscle stimulation to enable users to control finger movements and experience touch in a virtual space. Additionally, the company markets PossessedHand, a device worn on the forearm that applies electrical stimuli to control finger movements, making it suitable for rehabilitation and learning support applications. H2L is also exploring technologies that facilitate shared body experiences between users and virtual avatars, enhancing engagement in gaming and immersive environments.

Embr Labs

Series B in 2019
Embr Labs Inc. is a company based in Somerville, Massachusetts, that specializes in developing thermal comfort devices aimed at enhancing human well-being. Founded in 2014 and originally known as Wristify Inc., Embr Labs has created innovative technology that uses temperature to influence the autonomic nervous system, helping users manage conditions such as hot flashes, sleep disturbances, and anxiety. The company's wearable devices, combined with a mobile app and cloud infrastructure, provide a unique platform for thermal stimulation and digital interventions, allowing users to track and manage their symptoms effectively. With tens of thousands of customers across 170 countries, Embr Labs has recorded over 100 million minutes of thermal interventions. The technology originated from the founders' work as engineering students at MIT and has received significant backing from investors and over $2.5 million in grants from various organizations.

Limbic

Convertible Note in 2019
Limbic is a London-based company that specializes in mental healthcare technology. Founded in 2017, it develops a software development kit (SDK) that leverages machine learning to analyze heart rate data collected from wearable devices like the Apple Watch, allowing for the assessment of users' emotional states. Limbic also offers psychological therapies for adults, focusing on improving mental health through innovative solutions. Its platform supports healthcare professionals by providing tools for stress detection and facilitating clinical assessments, thereby enhancing the efficacy of psychological therapy. By combining AI technology with wearable devices, Limbic aims to address the growing challenges in mental health care and improve patient outcomes.

FIGUR8

Seed Round in 2019
Figur8, Inc. is a Boston-based company that specializes in developing advanced wearable sensors to monitor body movement as a biomarker for musculoskeletal (MSK) conditions. Founded in 2016 as a spin-off from MIT, Figur8 combines smart biosensors, intuitive software, and artificial intelligence to analyze MSK health data. The technology captures three-dimensional skeletal movement and muscle output, allowing for objective assessment of musculoskeletal performance and recovery. This innovative solution provides valuable insights throughout the entire care process, from injury to full recovery, ultimately reducing healthcare costs, improving access to treatment, and empowering patients to manage their own MSK health effectively.

UnaliWear

Seed Round in 2019
Focus groups have named our Kanega watch a wearable “OnStar for People” because we provide discreet support for falls, medication reminders, and a guard against wandering in a classically-styled watch that features an easy-to-use speech interface rather than buttons. Thanks to our patented battery system in the band, you never have to take your watch off to charge - and we don’t require a smart phone (because it's built in). We combine cellular, Wi-Fi, GPS, BLE (for hearing aids and telemedicine devices), an accelerometer for automatic fall detection, and continuous speech to provide an active medical alert that works anywhere, along with data-driven artificial intelligence that learns the wearer's lifestyle (think "NEST for people") to provide predictive, pre-emptive support.

Caura

Seed Round in 2019
Caura Ltd. is a London-based company established in 2018 that specializes in vehicle management solutions. The company offers a platform that enables drivers to efficiently handle various aspects of car ownership, including payments for parking, tolls, congestion charges, MOTs, vehicle tax, and insurance. Additionally, Caura provides a product called Caura Protect, which allows users to purchase and manage motor insurance through a network of insurers. The company also focuses on developing microelectronic devices that monitor health metrics such as lactate and glucose levels, along with heart-rate and accelerometry data. Furthermore, Caura creates application software that connects to these devices to generate reports and analyze the collected data.

IrisVision

Seed Round in 2019
IrisVision is the global leader in digital vision technologies. We have developed the world’s first and only smart visual assistive device built on wearable VR technology to help millions of vision-impaired people regain their sight, achieve independence, and do the things they love.

Neosensory

Series A in 2019
Neosensory focus on sending a variety of data streams to the brain via the sense of touch. With so much unused real estate on the body, the skin presents huge potential for the delivery of new information. They are currently building the world’s first hearing assistive technology that enables people to listen with their skin.

Neurosity

Seed Round in 2018
Neurosity Inc., founded in 2018 and based in New York, specializes in thought-powered wearable devices that interpret brain activity to enhance productivity and focus. The company's flagship product, the Notion, integrates hardware and software to help users, particularly programmers, improve their concentration and extend their focus time. By utilizing brain wave data, Neurosity's neural devices facilitate a deeper understanding of thoughts, feelings, and movements, allowing users to translate their cognitive states into actionable outputs. This innovative approach empowers individuals to measure their brain activity and engage with personalized applications directly on the device, fostering new experiences driven by their thoughts.

Epicore Biosystems

Seed Round in 2018
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company founded in 2017 that specializes in developing and commercializing a wearable microfluidic sensing platform. This innovative technology analyzes small droplets of sweat directly from the skin to provide insights into health, hydration, and athletic performance. The platform is designed to measure various biomarkers, including proteomics and inflammatory markers, allowing for personalized management of health and nutrition. Epicore's approach leverages over two decades of research in microfluidics and soft materials conducted by leading experts at Northwestern University. By offering a non-invasive and cost-effective solution, Epicore aims to enhance athletic performance and improve overall health monitoring for users.

Noctrix Health

Pre Seed Round in 2018
Noctrix Health, Inc. is an early-stage medical device company based in Menlo Park, California, founded in 2018. The company specializes in developing therapeutic wearable devices aimed at treating chronic neurological and sleep disorders, particularly focusing on restless leg syndrome. Its innovative device utilizes neural circuitry to alleviate symptoms and promote undisturbed sleep, empowering patients to better manage their chronic medical conditions.

Flux Bioscience

Seed Round in 2018
Flux Bioscience is a company that originated from Stanford University, focusing on innovative point-of-care in vitro medical diagnostics. It has developed a portable biosensor platform designed to deliver medical-grade diagnostics directly to patients' homes. Utilizing a technology initially designed for reading and writing computer hard drives, Flux's platform analyzes blood, urine, or saliva samples to measure various biomarkers related to exercise, stress, fertility, and diet. These measurements are correlated with sleep and activity data obtained from wearable technologies. The biosensors are equipped with biochips that can detect multiple biomarkers simultaneously, providing accurate and sensitive real-time results through antibody-antigen interactions with magnetic nanoparticles. This approach empowers individuals to take charge of their healthcare and make informed lifestyle decisions.

Neosensory

Convertible Note in 2018
Neosensory focus on sending a variety of data streams to the brain via the sense of touch. With so much unused real estate on the body, the skin presents huge potential for the delivery of new information. They are currently building the world’s first hearing assistive technology that enables people to listen with their skin.

Weaver Labs

Seed Round in 2014
The Apple Watch fundamentally transforms their relationship with technology in a way that is personal, yet it disappears into everyday activity. Its form factor provides them with more agency and context than ever before. They send a quarter of a trillion messages each day, yet mobile communication has changed little in 20 years. Text messaging assumes a keyboard is present. However, typing can be rude, unsafe and downright inconvenient. Weaver is a platform crafted from the ground up to reinvent messaging for a new type of ‘on-the-go’ lifestyle. It recommends context-aware conversations for the Apple Watch and the more than 2 billion devices running iOS and Android -- without the need for a keyboard or a camera. Weaver knows where you are in a conversation -- predicting and conveniently suggesting a series of cue cards with which you can respond via a simple tap. Weaver empowers users to communicate at a glance to express body language, character, place and style.

FocusMotion Health

Seed Round in 2013
FocusMotion is a company that specializes in fitness and orthopedic recovery technology. It develops innovative devices, including a smart knee brace and wrist sensors, to enhance the tracking and quantification of physical activity. The company offers TRAINR, a fitness software that automatically quantifies workouts while providing a virtual training environment for users to receive ongoing feedback. FocusMotion's technology integrates with smartwatches and fitness bands, enabling both users and physicians to monitor and analyze movements, exercise levels, and recovery progress through advanced sensor data. This approach aims to support individuals in achieving their fitness goals and assists healthcare professionals in evaluating patient rehabilitation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.